Krebs Biochem

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE268B01013
  • NSEID: KREBSBIO
  • BSEID: 524518
INR
57.00
-0.25 (-0.44%)
BSENSE

Aug 10

BSE+NSE Vol: 6.93 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 142337,
    "name": "Krebs Biochem",
    "stock_name": "Krebs Biochem",
    "full_name": "Krebs Biochemicals & Industries Ltd",
    "name_url": "stocks-analysis/krebs-biochem",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "57.00",
    "chg": -0.25,
    "chgp": "-0.44%",
    "dir": -1,
    "prev_price": "57.25",
    "mcapval": "129.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524518,
    "symbol": "KREBSBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE268B01013",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "6.93 k",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/krebs-biochem-142337-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Krebs Biochemicals & Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/krebs-biochemicals-industries-ltd-is-rated-strong-sell-4002795",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KrebsBiochemica_mojoScore_4002795.png",
        "date": "2026-05-21 10:10:22",
        "description": "Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 Feb 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd Locks at Lower Circuit With 4.02% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/krebs-biochemicals-industries-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4001044",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KrebsBiochemica_stocks_hitting_lower_circuit_4001044.png",
        "date": "2026-05-20 12:00:07",
        "description": "At Rs 55.58, Krebs Biochemicals & Industries Ltd locked at its lower circuit of 4.02% on 20 May 2026, with sellers lined up but no buyers willing to absorb the supply. The 5% price band limited the daily loss, yet the unfilled sell orders highlight persistent selling pressure and a frozen price."
      }
    ],
    "total": 15,
    "sid": "142337",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/krebs-biochemicals-industries-142337"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Aug-2026",
      "details": "The Company has enclosed herewith copy of newpapers advertiesment of unaudited financial results for the quarter ended 30.06.2026",
      "source": "BSE"
    },
    {
      "caption": "Results",
      "datetime": "06-Aug-2026",
      "details": "Results for the quarter ended 30602026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of BM",
      "datetime": "06-Aug-2026",
      "details": "Outcome of BM",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Krebs Biochemicals & Industries Ltd has announced <strong>21:100</strong> rights issue, ex-date: 31 Jan 19",
          "dt": "2019-01-31",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

07-Aug-2026 | Source : BSE

The Company has enclosed herewith copy of newpapers advertiesment of unaudited financial results for the quarter ended 30.06.2026

Results

06-Aug-2026 | Source : BSE

Results for the quarter ended 30602026

Board Meeting Outcome for Outcome Of BM

06-Aug-2026 | Source : BSE

Outcome of BM

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Krebs Biochemicals & Industries Ltd has announced 21:100 rights issue, ex-date: 31 Jan 19